Cargando…

Corrigendum: Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy

Detalles Bibliográficos
Autores principales: Guo, Yangyang, Cen, Kenan, Chen, Qiaoqiao, Dai, Ying, Mai, Yifeng, Hong, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277856/
https://www.ncbi.nlm.nih.gov/pubmed/37342331
http://dx.doi.org/10.3389/fimmu.2023.1229541
_version_ 1785060375886036992
author Guo, Yangyang
Cen, Kenan
Chen, Qiaoqiao
Dai, Ying
Mai, Yifeng
Hong, Kai
author_facet Guo, Yangyang
Cen, Kenan
Chen, Qiaoqiao
Dai, Ying
Mai, Yifeng
Hong, Kai
author_sort Guo, Yangyang
collection PubMed
description
format Online
Article
Text
id pubmed-10277856
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102778562023-06-20 Corrigendum: Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy Guo, Yangyang Cen, Kenan Chen, Qiaoqiao Dai, Ying Mai, Yifeng Hong, Kai Front Immunol Immunology Frontiers Media S.A. 2023-06-05 /pmc/articles/PMC10277856/ /pubmed/37342331 http://dx.doi.org/10.3389/fimmu.2023.1229541 Text en Copyright © 2023 Guo, Cen, Chen, Dai, Mai and Hong https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Guo, Yangyang
Cen, Kenan
Chen, Qiaoqiao
Dai, Ying
Mai, Yifeng
Hong, Kai
Corrigendum: Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy
title Corrigendum: Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy
title_full Corrigendum: Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy
title_fullStr Corrigendum: Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy
title_full_unstemmed Corrigendum: Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy
title_short Corrigendum: Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy
title_sort corrigendum: identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277856/
https://www.ncbi.nlm.nih.gov/pubmed/37342331
http://dx.doi.org/10.3389/fimmu.2023.1229541
work_keys_str_mv AT guoyangyang corrigendumidentificationandvalidationofanovelsenescencerelatedbiomarkerforthyroidcancertopredicttheprognosisandimmunotherapy
AT cenkenan corrigendumidentificationandvalidationofanovelsenescencerelatedbiomarkerforthyroidcancertopredicttheprognosisandimmunotherapy
AT chenqiaoqiao corrigendumidentificationandvalidationofanovelsenescencerelatedbiomarkerforthyroidcancertopredicttheprognosisandimmunotherapy
AT daiying corrigendumidentificationandvalidationofanovelsenescencerelatedbiomarkerforthyroidcancertopredicttheprognosisandimmunotherapy
AT maiyifeng corrigendumidentificationandvalidationofanovelsenescencerelatedbiomarkerforthyroidcancertopredicttheprognosisandimmunotherapy
AT hongkai corrigendumidentificationandvalidationofanovelsenescencerelatedbiomarkerforthyroidcancertopredicttheprognosisandimmunotherapy